Meiwu Technology Co Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Meiwu Technology Co Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1.08	7.68	22.1	12.3	11	11	0.16	7.08
Cost of revenue	0.85	5.78	18	9.42	9.8	8.39	0.09	6.37
Gross profit	0.23	1.9	4.16	2.84	1.17	2.58	0.07	0.71
Research and development	0.21	0.34	0.53	0.45	1.03	0.11	0	2.69
Selling and marketing	0.32	1.88	3.99	1.47	1.08	1.46	0.09	3.01
General and administrative	0.68	1.44	1.87	2.02	2.8	2.53	2.02	3.81
Operating expenses	1.21	3.66	6.4	3.94	4.91	4.1	2.11	9.5
Operating income	-0.98	-1.76	-2.24	-1.1	-3.74	-1.52	-2.05	-8.79
Other non-operating income	0	0	0.02	0.1	-0.55	0.14	0.02	0.43
Pre-tax income	-0.98	-1.76	-2.22	-1.12	-11	-16.1	4.74	-18.2
Income tax					0.21	0.21	-0.37
Net income to minority interests				-0.04	-0.15	-0.25		0.4
Net income	-1.1	-1.76	-2.22	-1.08	-11.1	-16.1	5.11	-18.6
EBITDA	-0.92	-1.66	-1.93	-0.71	-3.65	-1.33	-1.92	-5.9
EPS, basic	-1.94	-3.56	-3.88	-0.97	-10.04	-6.28	0.45	-0.82
EPS, diluted	-1.94	-3.56	-3.88	-0.97	-10.04	-6.28	0.45	-0.82
Shares, basic (weighted)	0.46	0.48	0.62	0.74	1.27	2.6	11.3	22.1
Shares, diluted (weighted)	0.46	0.48	0.62	0.74	1.27	2.6	11.3	22.1

Balance sheet

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents		0.55	7.03	26.6	23.7	16.1	43.4	17.9
Short-term investments		0.07
Receivables			0.44	0.43	4.04	2.87		0.99
Inventory		0.25	1.53	0.43	0.34	0.1		0.08
Other current assets		0.03	0.15	0.26	0.39	0.47	1	0.55
Total current assets		1.63	36.4	28	29.9	20.4	60.9	20.8
Property, plant and equipment		0.33	0.3	0.28	0.18	0.08
Lease right-of-use assets		0.93	0.75	0.02	0.23	0.12		0.04
Goodwill					7.7
Intangible assets								29.9
Total assets	1.87	3.24	37.5	28.3	38	20.6	60.9	50.7
Accounts payable		1.16	5.69	1.66	4.99	2.55	0.02	0.87
Accrued liabilities		0.37	1.7	0.93	1.96	3.12	0.23	0.43
Deferred revenue		1.45	5.33	1.15	0.75	1	0.43	0.01
Short-term debt				0.05	0.33	0.42
Total current liabilities		3.22	13	3.81	8.35	7.64	0.68	1.32
Long-term debt				0.41	0.22
Lease liabilities		0.77	0.55		0.14	0.02		0.02
Other non-current liabilities					3.68	3.91	1.29
Total liabilities		4.89	20.6	10.7	17.9	11.6	1.97	1.34
Total debt				0.46	0.55
Paid-in capital		1	22	23.4	38.6	44.5	92.7	101
Retained earnings		-2.71	-4.93	-6.01	-17.1	-33.1	-28	-46.6
Other comprehensive income		0.06	-0.15	0.25	-1.28	-1.95	-5.3	-5.22
Shareholders' equity	-0.82	-1.65	16.9	17.6	20.2	9.41	59.4	49.4
Minority interests				-0	-0.15	-0.4	-0.4
Total equity	-0.82	-1.65	16.9	17.6	20.1	9.02	59	49.4
Total liabilities and equity		3.24	37.5	28.3	38	20.6	60.9	50.7
Shares outstanding		0.62	0.77	33	1.74	2.92	0.03	0.16

Cash flow statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-1.1	-1.76	-2.22	-1.12	-11.2	-16.3	5.11	-18.2
Depreciation and amortization	0.06	0.1	0.31	0.39	0.09	0.18	0.13	2.89
Stock-based compensation							0.44	0.83
Change in receivables	0.05		-0.42	0.02	-4.1	1.03	1.11	-0.99
Change in inventory	-0.05	-0.21	-1.2	1.12	0.09	0.24		-0.08
Change in payables	0.4	0.79	4.2	-4.12	3.33	-2.31	-0.75	0.85
Cash from operations	-0.53	-0.41	4.85	-8.69	-5.52	-0.5	-13.6	9.04
Capital expenditures	-0.03	-0.08	-0.03	-0.08	-0.03	-0.01
Cash from investing	-0.3	-0.15	-26.5	26.4	-0.03	-6.93	-0.94	-41
Debt issued				0.46	0.29
Stock issued							47.7	7.7
Cash from financing	0.92	1	27.7	1.11	2.88	0.28	45.5	6.41
Net change in cash	0.09	0.45	6.48	19.6	-2.92	-7.65	27.3	-25.5
Free cash flow	-0.56	-0.49	4.82	-8.77	-5.55	-0.51

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.52 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	10.1%	Gross profit / revenue.
Operating margin	-124.1%	Operating income / revenue.
EBITDA margin	-83.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-256.9%	Pre-tax income / revenue.
Net margin	-262.5%	Net income / revenue.
Operating cash flow margin	127.6%	Cash from operations / revenue.
Return on equity (ROE)	-34.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-33.3%	Net income / average total assets.
Return on invested capital (ROIC)	-29.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	37.9%	Research and development expense / revenue.
Stock-based pay / revenue	11.7%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	40.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4,368.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-13.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-20.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	964.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-15.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-29.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-463.5%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-282.2%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	13.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-16.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	34.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	23.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-16.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	10.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	95.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	159.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	104.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	15.8x	Current assets / current liabilities.
Quick ratio	14.3x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	13.6x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	2.6%	Total liabilities / total assets.
Working capital	$19.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	58.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$19.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.13x	Revenue / average total assets.
Inventory turnover	76.9x	Cost of revenue / average inventory.
Days inventory	5 days	365 x average inventory / cost of revenue.
Receivables turnover	7.15x	Revenue / average receivables.
Days sales outstanding	51 days	365 x average receivables / revenue.
Days payables	25 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	30 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.82	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$0.82	Net income per basic share, as reported (split-adjusted).
Revenue per share	$0.32	Revenue / diluted weighted shares.
Operating cash flow per share	$0.41	Cash from operations / diluted weighted shares.
Book value per share	$315.76	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$124.69	Tangible book value / shares outstanding.
Cash per share	$114.33	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$66.4M	Share price x shares outstanding.
Enterprise value	$48.5M	Market cap + total debt - cash - short-term investments.
P/S	9.37x	Market cap / revenue.
P/B	1.34x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.40x	Market cap / tangible book value, when positive.
P/OCF	7.34x	Market cap / cash from operations, when positive.
EV/Sales	6.84x	Enterprise value / revenue.
Earnings yield	-28.0%	Net income / market cap (the inverse of P/E).

What was Meiwu Technology Co Ltd's revenue in fiscal 2025?

Meiwu Technology Co Ltd reported revenue of $7.1M for fiscal 2025, 4,368% higher than the year before.

Was Meiwu Technology Co Ltd profitable in fiscal 2025?

No. It reported a net loss of $18.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Meiwu Technology Co Ltd